Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells
Open accessAbstract
Inhibiting osteoclasts and osteoclast precursors to reduce bone resorption is an important strategy to treat osteoclast-related diseases, such as osteoporosis, inflammatory bone loss, and malignant bone metastasis. However, the mechanism by which apoptosis is induced in the osteoclasts and their precursors are not completely understood. Here, we used nitrogen-containing bisphosphonate zoledronic acid (ZA) to induce cell apoptosis in human and murine osteoclast precursors and mature osteoclast-like cells. Caspase-3-mediated cell apoptosis occurred following the ZA (100 μM) treatment. Reactive oxygen species (ROS) were also generated in a time-dependent manner. Following knock-down of the p47 phox expression, which is required for ROS activation, or co-treatment with the ROS inhibitor, N-acetyl-L-cysteine, ZA-induced apoptosis was significantly suppressed in both osteoclast precursors and mature osteoclast-like cells. The ROS-activated mitogen-activated protein kinases pathways did not trigger cell apoptosis. However, a ROS-regulated Mcl-1 decrease simultaneously with glycogen synthase kinase (GSK)-3β promoted cell apoptosis. These findings show that ZA induces apoptosis in osteoclast precursors and mature osteoclast-like cells by triggering ROS- and GSK-3β-mediated Mcl-1 down-regulation.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ROS play an important role in age-induced loss of bone mass and osteoporosis.
“Reactive oxygen species (ROS) and oxidative stress play an important role in a number of physiological and pathological conditions, including age-indued loss of bone mass and osteoporosis [51].”
From A tailored bioactive 3D porous poly(lactic-acid)-exosome scaffold with osteo-immunomodulatory and osteogenic differentiation properties (2022) · cites this paper as [51]
The paper’s background discussion (indexed under Abstract; page unavailable) says ROS can be hazardous in aging and osteoporosis, and that oxidative damage can suppress osteogenesis while low ROS levels may stimulate bone resorption. It does not specifically link ROS to age-induced loss of bone mass, and its experiments concern zoledronic-acid-induced apoptosis rather than aging. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855 · see citing works
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989 · see citing works
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · see citing works
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930 · see citing works
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
Burge, R., Dawson-Hughes, B., Solomon, D. H., Wong, J. B., King, A., & Tosteson, A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061113 · Cited by 4,026 · see citing works
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837 · see citing works
Epidemiology and outcomes of osteoporotic fractures
Cummings, S. R., & Melton, L. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08657-9 · Cited by 3,821 · see citing works
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986 · see citing works
Reactive oxygen species in cell signaling
Thannickal, V. J., & Fanburg, B. L. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1005 · Cited by 2,936 · see citing works
Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?
Halliwell, B. B. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92211-x · Cited by 2,926 · see citing works
Diagnosis of osteoporosis and assessment of fracture risk
Kanis, J. А. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08761-5 · Cited by 2,266 · see citing works
Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture
Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa074941 · Cited by 2,003 · see citing works
ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis
Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K., Takeda, K., Minowa, O., Miyazono, K., Noda, T., & Ichijo, H. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve046 · Cited by 1,213 · see citing works
Oxidative stress: the paradox of aerobic life
Davies, K. J. A. (1995) · Biochemical Society Symposia · doi:10.1042/bss0610001 · Cited by 1,150 · see citing works
Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881 · see citing works
Garrett, I. R., Boyce, B. F., Oreffo, R. O. C., Bonewald, L. F., Poser, J. W., & Mundy, G. R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114485 · Cited by 807 · see citing works
Biochemical Markers of Bone Metabolism: An Overview
Christenson, R. H. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(97)00113-6 · Cited by 544 · see citing works
Wang, W., Chen, J. X., Liao, R., Deng, Q., Zhou, J. J., Huang, S., & Sun, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3389-3403.2002 · Cited by 376 · see citing works
Coxon, F. P., Helfrich, M., Hof, R. V., Sebti, S. M., Ralston, S. H., Hamilton, A. D., & Rogers, M. J. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1467 · Cited by 361 · see citing works
Peculiarities of cell death mechanisms in neutrophils
Geering, B., & Simon, H.-U. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.75 · Cited by 301 · see citing works
Constitutive neutrophil apoptosis: Mechanisms and regulation
Luo, H. R., & Loison, F. (2007) · American Journal of Hematology · doi:10.1002/ajh.21078 · Cited by 300 · see citing works
Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro
Benford, H. L., McGowan, N. W. A., Helfrich, M., NUTTALL, M. E., & Rogers, M. J. (2001) · Bone · doi:10.1016/s8756-3282(01)00412-4 · Cited by 235 · see citing works
Effects of Intravenous Zoledronic Acid Once Yearly on Bone Remodeling and Bone Structure
Recker, R. R., Delmas, P. D., Halse, J., Reid, I. R., Boonen, S., García-Hernández, P. A., Supronik, J., Lewiecki, E. M., Ochoa, L. A., Miller, P. D., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070906 · Cited by 224 · see citing works
Koh, J., Lee, Y., Kim, Y. S., Kim, D. J., Kim, H., Park, J., Lee, K., & Kim, G. S. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060406 · Cited by 202 · see citing works
Oncogenes in Cell Survival and Cell DeathPreprint
Shortt, J., & Johnstone, R. W. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009829 · Cited by 195 · see citing works
Efficacy of Bisphosphonates in Reducing Fracture Risk in Postmenopausal Osteoporosis
Bilezikian, J. P. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.12.003 · Cited by 166 · see citing works
Wang, X., Liu, J. Z., Hu, J. X., Wu, H., Li, Y. L., Chen, H. L., Bai, H., & Hai, C. X. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.019 · Cited by 146 · see citing works
Chiu, W. C., Luo, S.-J., Chen, C., Cheng, J., Hsieh, C.-Y., Wang, C., Huang, W., Su, W., & Lin, C. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.016 · Cited by 103 · see citing works
Self-citationJia, Y., Wei, W., Ma, B., Xu, Y., Liu, W., Wang, Y., Lv, K., Tang, H., Wei, D., & Xia, Z. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7808 · Cited by 97 · see citing works
Huang, Q., Gao, B., Jie, Q., Wei, B.-Y., Fan, J., Zhang, H.-Y., Zhang, J., Li, X., Shi, J., Luo, Z., et al. (2014) · Bone · doi:10.1016/j.bone.2014.06.010 · Cited by 96 · see citing works
Osteoclast Apoptosis: The Role of Fasin Vivoandin Vitro
Wu, X., McKenna, M. A., Feng, X., Nagy, T. R., & McDonald, J. M. (2003) · Endocrinology · doi:10.1210/en.2003-0296 · Cited by 93 · see citing works
Shi, J., Wang, L., Zhang, H., Jie, Q., Li, X., Shi, Q., Huang, Q., Gao, B., Han, Y., Guo, K. X., et al. (2015) · Bone · doi:10.1016/j.bone.2015.06.014 · Cited by 90 · see citing works
Simvastatin inhibits osteoclast differentiation by scavenging reactive oxygen species
Moon, H., Kim, S. E., Yun, Y.-P., Hwang, Y., Bang, J. B., Park, J.-H., & Kwon, I. K. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.11.067 · Cited by 89 · see citing works
Tsai, C., Kai, J.-I., Huang, W., Wang, C., Wang, Y., Chen, C., Fang, Y.-T., Lin, Y.-S., Anderson, R., Chen, S., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804033 · Cited by 81 · see citing works
Self-citationActive caspase‐3 is required for osteoclast differentiation
Szymczyk, K. H., Freeman, T., Adams, C. S., Srinivas, V., & Steinbeck, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20770 · Cited by 80 · see citing works
Lee, S., Kim, J., & Jang, H. D. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150610605 · Cited by 80 · see citing works
Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence
Rabenda, V., Hiligsmann, M., & Reginster, J. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903140533 · Cited by 78 · see citing works
Kyung, T.-W., Lee, J.-E., Shin, H., & Choi, H.-S. (2008) · Experimental and Molecular Medicine · doi:10.3858/emm.2008.40.1.52 · Cited by 67 · see citing works
MCL-1 Inhibits BAX in the Absence of MCL-1/BAX Interaction
Germain, M., Milburn, J., & Duronio, V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707762200 · Cited by 64 · see citing works
Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women
Lambrinoudaki, I. V. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s2046 · Cited by 62 · see citing works
Faust, D., Schmitt, C. R., Oesch, F., Oesch‐Bartlomowicz, B., Schreck, I., Weiß, C., & Dietrich, C. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-6 · Cited by 62 · see citing works
NADPH Oxidases in Redox Regulation of Cell Adhesion and Migration
Schröder, K. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5633 · Cited by 60 · see citing works
Bruzzese, F., Pucci, B., Milone, M. R., Ciardiello, C., Franco, R., Chianese, M. I., Rocco, M., Gennaro, E. D., Leone, A., Luciano, A., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.406 · Cited by 58 · see citing works
Chen, C., Lin, C., Wan, S.-W., Wei, L.-S., Chen, M.-C., Yeh, T., Liu, H., Anderson, R., & Lin, Y.-S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201976 · Cited by 49 · see citing works
Self-citationSmietana, M. J., Arruda, E. M., Faulkner, J. A., Brooks, S. V., & Larkin, L. M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.006 · Cited by 49 · see citing works
Negative Feedback Loop in the Bim–Caspase-3 Axis Regulating Apoptosis and Activity of Osteoclasts
Wakeyama, H., Akiyama, T., Takahashi, K., Amano, H., Kadono, Y., Nakamura, M., Oshima, Y., Itabe, H., Nakayama, K., Nakayama, K., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070619 · Cited by 46 · see citing works
Hsing, C., Chen, Y., Chen, C., Huang, W., Lin, M.-C., Tseng, P., Wang, C., Tsai, C., Choi, P.-C., & Lin, C. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31824af68a · Cited by 38 · see citing works
Self-citationTai, T., Su, F., Chen, C., Jou, I., & Lin, C. (2014) · Bone · doi:10.1016/j.bone.2014.07.003 · Cited by 37 · see citing works
Self-citationOursler, M. J., Bradley, E. W., Elfering, S. L., & Giulivi, C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00092.2004 · Cited by 37 · see citing works
Ge, X., Yang, L., Jiang, Y. Z., Yang, W., Fu, J., & Li, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101207 · Cited by 36 · see citing works
NADPH oxidase activity: In the crossroad of neutrophil life and death
Arruda, M. A. (2009) · Frontiers in bioscience · doi:10.2741/3547 · Cited by 35 · see citing works
Wang, C., Yang, T.-T., Chen, C., Lin, W., & Lin, C. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.021 · Cited by 32 · see citing works
Self-citationCaspase-2 Maintains Bone Homeostasis by Inducing Apoptosis of Oxidatively-Damaged Osteoclasts
Sharma, R., Callaway, D. A., Vanegas, D., Bendele, M., Lopez‐Cruzan, M., Horn, D., Guda, T., Fajardo, R. J., Abboud‐Werner, S. L., & Herman, B. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093696 · Cited by 31 · see citing works
COLLI, M. D., Zara, S., di Giacomo, V., Patruno, A., Marconi, G. D., Gallorini, M., Zizzari, V. L., Tetè, G., & Cataldi, A. (2014) · Clinical Oral Investigations · doi:10.1007/s00784-014-1344-9 · Cited by 21 · see citing works
Koto, K., Murata, H., Kimura, S. H., SAWAI, Y., Horie, N., Matsui, T., Ryu, K., Ashihara, E., Maekawa, T., Kubo, T., et al. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1735 · Cited by 13 · see citing works
Targeting NOX4 knocks down osteoporosis
Harrison, C. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4182 · Cited by 12 · see citing works
Risedronate's efficacy: from randomized clinical trials to real clinical practice.
Iolascon, G., Sirico, F., Ferrante, A., Gimigliano, R., & Gimigliano, F. (2010) · PubMed Central · Cited by 7 · see citing works
High levels of ROS block the differentiation of human and mouse osteoclasts (100.5)
Moreno, J. L., Celluzzi, C. M., Keegan, A. D., & Williams, M. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.supp.100.5 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Agidigbi, T. S., & Kim, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143576 · Cited by 518 · see citing works
Selenoprotein W ensures physiological bone remodeling by preventing hyperactivity of osteoclasts
Kim, H., Lee, K., Kim, J., Kim, M. Y., Kim, J.-R., Lee, H., Chung, Y. W., Shin, H.-I., Kim, T. S., Park, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22565-7 · Cited by 83 · see citing works
ER Stress, the Unfolded Protein Response and Osteoclastogenesis: A Review
Huang, W., Gong, Y., & Yan, L. W. (2023) · Biomolecules · doi:10.3390/biom13071050 · Cited by 65 · see citing works
Photocatalytic Oxygenation and Deoxygenation Transformations over BCN Nanosheets
Zheng, M., Tao, Y., Shi, J., Cai, W., & Wang, X. (2019) · ACS Catalysis · doi:10.1021/acscatal.9b02550 · Cited by 62 · see citing works
Li, M., Wan, P., Wang, W., Yang, K., Zhang, Y., & Han, Y. N. (2019) · Scientific Reports · doi:10.1038/s41598-018-37091-8 · Cited by 56 · see citing works
Huang, X., Lan, Y., Shen, J., Zhao, X., Zhou, Y., Wu, W., Mao, J., Wu, Y., Xie, Z., & Chen, Z. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.02.005 · Cited by 56 · see citing works
How zoledronic acid improves osteoporosis by acting on osteoclasts
Wang, B., Zhan, Y., Yan, L. W., & Hao, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.961941 · Cited by 52 · see citing works
Tao, S., Yu, H., You, T., Kong, X., Wei, X., Zheng, Z., Zheng, L., Feng, Z., Huang, B. H., Zhang, X., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c03828 · Cited by 52 · see citing works
Vito, A. D., Chiarella, E., Baudi, F., Scardamaglia, P., Antonelli, A., Giudice, D., Barni, T., Fortunato, L., & Giudice, A. (2020) · Cell Transplantation · doi:10.1177/0963689720948497 · Cited by 49 · see citing works
Huang, X., Huang, L., Cheng, Y., Li, F., Zhou, Q., Wu, C., Shi, Q., Guan, Z., Liao, J., & Hong, W. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4207 · Cited by 49 · see citing works
Taniguchi, N., Osaki, M., Onuma, K., Ishikawa, M., Ryoke, K., Kodani, I., & Okada, F. (2019) · Journal of Periodontology · doi:10.1002/jper.19-0385 · Cited by 46 · see citing works
Xu, H., Yin, D., Liu, T., Chen, F., Chen, Y., Wang, X., & Sheng, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.125 · Cited by 44 · see citing works
Zhang, Y., Huo, M., Wang, Y., Xiao, L., Wu, J., Ma, Y., Zhang, D., Lang, X., & Wang, X. (2022) · Journal of Biological Engineering · doi:10.1186/s13036-022-00301-z · Cited by 43 · see citing works
Sing, C., Kiel, D. P., Hubbard, R., Lau, W. C. Y., Li, G. H., Kung, A. W. C., Wong, I. C. K., & Cheung, C. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4030 · Cited by 39 · see citing works
Singh, V., Naldi, A., Soliman, S., & Niarakis, A. (2023) · npj Systems Biology and Applications · doi:10.1038/s41540-023-00294-5 · Cited by 28 · see citing works
Ma, X., Wen, X., Yang, X., Zhou, D., Wu, Q., Feng, Y., Ding, H.-J., Lei, W., Yu, H., Liu, B., et al. (2018) · Biochimie · doi:10.1016/j.biochi.2018.04.022 · Cited by 27 · see citing works
Faham, S., Ghavami, R., Golmohammadi, H., & Khayatian, G. (2019) · Microchimica Acta · doi:10.1007/s00604-019-3815-9 · Cited by 22 · see citing works
Lee, Y. M., Kim, I. S., & Lim, B. O. (2019) · BioMed Research International · doi:10.1155/2019/5073085 · Cited by 19 · see citing works
Kameda, Y., Aizawa, M., Sato, T., & Honda, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041889 · Cited by 18 · see citing works
Cheng, Y., Liao, J., Zhou, Q., Huo, H., Zellmer, L., Tang, Z., Ma, H., Hong, W., & Liao, D. J. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211011052 · Cited by 17 · see citing works
Xu, C., Jin, S., Jin, S., Dai, Z.-H., Wu, Y., He, G.-L., Ma, H., Xu, C.-Y., & Fang, W. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109893 · Cited by 15 · see citing works
Lu, Y., Lu, D., & Hu, Y. (2018) · Cell Proliferation · doi:10.1111/cpr.12443 · Cited by 12 · see citing works
Wang, L., Gao, H., Xiao-ya, Y., Liang, X., Tan, Q., Chen, Z., Zhao, C., Gu, Z., Yu, M., Zheng, Y., et al. (2018) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12979 · Cited by 11 · see citing works
Development of an In Vitro 3D Model for Investigating Ligamentum Flavum Hypertrophy
Lin, C., Kuo, Y.-T., Tsao, C.-H., Shyong, Y., Shih, S.-H., & Tu, T. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00132-6 · Cited by 11 · see citing works
Self-citationLiu, D., Du, J., Sun, J. Y., & Li, M. (2021) · Bioengineered · doi:10.1080/21655979.2021.1928930 · Cited by 10 · see citing works
Yoshioka, Y., Yamachika, E., Nakanishi, M., Ninomiya, T., Nakatsuji, K., Kobayashi, Y., Fujii, T., & Iida, S. (2018) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2018.08.003 · Cited by 9 · see citing works
Jin, Y., Tang, R., Yang, J., Chen, Y., & Fei, J. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9662 · Cited by 9 · see citing works
Zoledronic acid modulates human osteosarcoma cells proliferation via GSK-3β activation
Li, S., & Li, J. J. (2019) · Neoplasma · doi:10.4149/neo_2018_181128n904 · Cited by 9 · see citing works
Cho, J., Feldman, G. J., Tomlinson, R. E., Taub, D. I., & Diecidue, R. J. (2024) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2024.05.014 · Cited by 8 · see citing works
Zhao, W., Huang, Z., Lin, Y., Lan, J., & Gao, X. (2021) · BioMed Research International · doi:10.1155/2021/5578088 · Cited by 7 · see citing works
RetractedNakamura, M., Ueda, K., Yamamoto, Y., Aoki, K., Zhang, M., Saito, N., & Yudasaka, M. (2022) · Biomaterials Science · doi:10.1039/d2bm00822j · Cited by 6 · see citing works
AS-605240 Blunts Osteoporosis by Inhibition of Bone Resorption
Sun, J., Cai, G., Shen, J., Cheng, P., Zhang, J., Jiang, D., Xu, X., Lu, F., Chen, L., & Chen, H. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s403231 · Cited by 5 · see citing works
Liu, X., Tian, L., Deng, Z., Guo, Y., & Zhang, S. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00931-8 · Cited by 4 · see citing works
Sagoe, P. N. K., Zink, B., & Jain, E. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01889-7 · Cited by 4 · see citing works
Sadhasivam, D. R., Soundararajan, S., Elumalai, S., Karuppiah, P., & Al-Dhabi, N. A. (2020) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2020.101700 · Cited by 3 · see citing works
Inhibition of osteoclastogenesis after bisphosphonate therapy discontinuation: an in vitro approach
Bradaschia-Corrêa, V., Ribeiro-Santos, G., de Faria, L. P., Teixeira, P. R., & Arana-Chavez, V. E. (2022) · Journal of Molecular Histology · doi:10.1007/s10735-022-10083-9 · Cited by 3 · see citing works
Faienza, M. F., Tummolo, A., Celli, M., Finocchiaro, R., Piacente, L., Serio, F. D., Nicchia, G. P., Brunetti, G., & D’Eufemia, P. (2023) · Biomedicines · doi:10.3390/biomedicines11020458 · Cited by 3 · see citing works
Doroshow, J. H., & Gaur, S. (2020) · doi:10.20455/ros.2020.811 · Cited by 3 · see citing works
Osteoblastic cell responses to zoledronate treatment in-vitro: A systematic review
Florez-Martin, M., Radu, A.-M., Shakib, K., & Jell, G. (2026) · Bone · doi:10.1016/j.bone.2026.117796 · Cited by 2 · see citing works
Tang, L. F., Li, B., Su, Q., Chen, X., & He, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-39258-4 · Cited by 2 · see citing works
Zhao, X., Meng, T., Wang, K., Yan, X., Liu, Y., & Li, X. (2025) · Frontiers in Pain Research · doi:10.3389/fpain.2024.1512925 · Cited by 2 · see citing works
Cystatin M/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone Resorption
Gai, D., Caviness, P. C., Lazarenko, O. P., Chen, J. F., Randolph, C. E., Zhang, Z., Cheng, Y., Sun, F., Xu, H., Blackburn, M. L., et al. (2025) · Cancers · doi:10.3390/cancers17050833 · Cited by 1 · see citing works
[Risedronate inhibits rat bone marrow adipogenesis and reduces RANKL expression in adipocytes].
Jin, J., & Jin, D. (2019) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2019.08.17 · Cited by 1 · see citing works
Molecular docking of the active compound Garcinia mangostana on the RANKL/RANK/OPG system
Setiawan, B., Suhartono, E., Kaidah, S., Akbar, I. Z., & Noor, Z. (2019) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1374/1/012054 · Cited by 1 · see citing works
Gradual repression of selenoprotein W ensures physiological bone remodellingPreprint
Kim, H., Lee, K. H., Kim, J., Kim, J.-R., Lee, H., Chung, Y. W., Shin, H., Park, E., Rho, J., Lee, S. H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/254433 · Cited by 1 · see citing works
Cystatin M/E ameliorates bone resorption through increasing osteoclastic cell estrogen influxPreprint
Chen, J., Gai, D., Caviness, P. C., Lazarenko, O. P., Chen, J., Randolph, C., Zhang, Z., Cheng, Y., Sun, F., Xu, H., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4313179/v1 · Cited by 1 · see citing works
Karasu, B., Özcan, G., İşler, S. Ç., Akca, G., Kaymaz, Ö., & Bozkurt, S. (2025) · Cumhuriyet Dental Journal · doi:10.7126/cumudj.1411790
Lin, C.-L., Kuo, Y.-T., Tsao, C.-H., Shyong, Y.-J., Shih, S.-H., & Tu, T.-Y. (2020) · Figshare · doi:10.6084/m9.figshare.12900464
Self-citationCCAR2 reduces the number of osteoclasts by controlling osteoclast apoptosis
Zhang, J., Song, Y., Chen, S., Jang, K. Y., Kim, J. R., & Moon, Y. J. (2026) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2026052
Zhou, J., Su, H., Zhang, H., Dong, J., & Xiao, H. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-026-10811-5 · Cited by 1 · see citing works
Jiang, A., Liao, J., Shi, Y., Song, W., Luo, S., Li, L., & Zhang, Z. (2026) · Biomolecules · doi:10.3390/biom16091259
- Authors
- Tai, T.-W., Chen, C.-Y., Su, F.-C., Tu, Y.-K., Tsai, T.-T., Lin, C.-F., & Jou, I.-M.
- Affiliations
- National Cheng Kung University Hospital (TW)
- National Cheng Kung University (TW)
- E-Da Hospital (TW)
- Taipei Medical University (TW)
- Corresponding author
- Lin, Chiou-Feng
- Jou, I.-Ming
- Venue
- Scientific Reports
- Published
- 2017-03-10
- Volume
- 7
- Issue
- 1
- Pages
- 44245-44245
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5345019
- OpenAlex
- W2591659741
- Cited by
- 51
- References
- 58
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 3 · 2023: 8 · 2022: 4 · 2021: 5 · 2020: 6 · 2019: 10 · 2018: 7
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology, Taiwan (MOST 105-, MOST104-2314-B006-005-MY2, MOST105-2314-B006-016)
- National Cheng Kung University Hospital
- National Cheng Kung University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- zoledronic acid, reactive oxygen species, osteoclast apoptosis, osteoclast precursors, osteoclast-like cells, bisphosphonates, p47phox, N-acetylcysteine, Mcl-1, glycogen synthase kinase-3β, caspase-3, bone resorption, osteoporosis, bone metastasis
- MeSH terms
- RAW 264.7 Cells, Glycogen Synthase Kinase 3 beta, THP-1 Cells, Zoledronic Acid, Acetylcysteine, Animals, Cell Differentiation, Cells, Cultured, Diphosphonates, Humans, Imidazoles, Macrophages, Male, Mice, Inbred C57BL, Osteoclasts, Stem Cells, Apoptosis, Reactive Oxygen Species, HL-60 Cells, Mice, Caspase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review